Drugs / Gelofusine
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02541734 | Aug 2015 → May 2017 | type 2 diabetes mellitus | Radboud University Medical Center | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05647057 | Jul 2023 → Jul 2024 | — | Amsterdam UMC, location VUmc | Completed | No outcome recorded |
| — | NCT02461329 | May 2015 → Sep 2016 | bleeding disorder, vascular-type, blood platelet disease | Kratochvil Milan, MD | Unknown | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| Phase 1 | NCT03246659 Background | Aug 2016 → Nov 2018 | medullary thyroid gland carcinoma | Paola Anna Erba | Completed | No outcome recorded |
| Phase 2 | NCT00773110 Comparator | Dec 2008 → May 2011 | autoinflammatory syndrome | Imperial College London | Terminated | No outcome recorded Stop: Enrollment |
| Phase 3 | NCT02808325 Comparator | Jun 2016 → Jun 2017 | dehydration polycythemia | B. Braun Medical SA | Completed | No outcome recorded |
| — | NCT02071524 Comparator | Sep 2013 → Mar 2017 | — | Università degli Studi di Ferrara | Unknown | No outcome recorded |
| — | NCT01935791 Background | Jul 2013 → Nov 2018 | metabolic disease | Imperial College London | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | gelofusine | “Gelofusine (300 mL, 4% succinylated gelatin, a synthetic colloid)” NCT00773110 ↗7“Group Colloid: cristalloid 1:2 (gelofusine: ringer lactate)” NCT02071524 ↗ “receiving an infusion of gelofusine” NCT01935791 ↗ |
| Known as | succinylated gelatin | “One of these agents is succinylated gelatin (Gelofusine), a plasma expander that consists of a mixture of collagen-derived peptides.” NCT02541734 ↗ |
| Modality | Other / unclassified | “Gelofusine (300 mL, 4% succinylated gelatin, a synthetic colloid)” NCT00773110 ↗ |
| Route | Intravenous | “infusion via intravenous boluses” NCT02461329 ↗ |